Morphoea induced by treatment with interferon beta-1a

Br J Dermatol. 2020 Jan;182(1):244-246. doi: 10.1111/bjd.18357. Epub 2019 Sep 18.

Authors

E Peterson¹, A Steuer¹, L Franco², M A Nolan³, K Lo Sicco¹, A G Franks^{1

4}

Affiliations

¹ The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, U.S.A.
² Division of Dermatology, Albert Einstein College of Medicine, Montefiore, Bronx, New York, NY, U.S.A.
³ Division of Cardiovascular Disease, Northwell Health/Lenox Hill Hospital, New York, NY, U.S.A.
⁴ Division of Rheumatology, New York University School of Medicine, New York, NY, U.S.A.

PMID: 31323114
DOI: 10.1111/bjd.18357

No abstract available

Publication types

Letter

MeSH terms

Adjuvants, Immunologic
Humans
Interferon beta-1a / adverse effects
Interferon-beta / adverse effects
Scleroderma, Localized* / chemically induced
Scleroderma, Localized* / drug therapy
Treatment Outcome

Substances

Adjuvants, Immunologic
Interferon-beta
Interferon beta-1a